This inventor holds 18 USPTO granted patents and 9 published patent applications and 12 EPO patents, primarily in Respiratory Disease Treatment. Top assignees: Chiesi Farmaceutici S.p.a., Pulmagen Therapeutics (Inflammation) Limited, Pulmagen Therapeutics (Asthma) Limited. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Flex Meadow, GB (2013)
- Harlow, GB (2013)
- Essex, GB (2010 - 2015)
- Slough, GB (2013 - 2015)
- Buckinghamshire, GB (2014 - 2015)
- Parma, IT (2016)
Company Filing History:
6 out of 343 
5 out of 5 
4 out of 4 Years Active: 2010-2016
Areas of Expertise:
Title: The Innovative Mind of Harry Finch
Introduction
Harry Finch, an accomplished inventor based in Essex, GB, has made significant contributions to the world of pharmaceuticals. With a total of 18 patents to his name, Finch has focused on developing innovative solutions to combat various diseases, particularly those impacting the respiratory system.
Latest Patents
Among his latest inventions are kinase inhibitors, which consist of compounds featuring [1,2,4]triazolo[4,3-a]pyridine groups and their pharmaceutically acceptable salts. These compounds are particularly noteworthy as they serve as p38 MAPK inhibitors, which exhibit potential as anti-inflammatory agents for treating respiratory tract diseases. Additionally, Finch has developed pyrimidine derivatives aimed at treating respiratory diseases such as COPD. These compounds' formulas include inhibitors of neutrophil elastase, showcasing his dedication to advancing respiratory health through innovative chemistry.
Career Highlights
Finch's career has been marked by significant achievements in the pharmaceutical industry. He has worked with notable companies such as Chiesi Farmaceutici S.p.a. and Pulmagen Therapeutics Limited, where his focus on inflammation-related conditions has led to pivotal advancements in treatment options. His expertise in pharmacology and chemical innovation has enabled him to create compounds that address critical health issues.
Collaborations
Throughout his journey, Finch has collaborated with esteemed professionals in the field. Notable coworkers include Christine Edwards and Craig Fox, with whom he has partnered to further enhance the development of innovative therapeutic solutions. These collaborations have not only contributed to his success but also fostered a dynamic exchange of ideas that enrich the research environment.
Conclusion
Harry Finch stands out as a prolific inventor with a passion for tackling healthcare challenges through innovation. His commitment to developing effective treatments for respiratory diseases has resulted in an impressive portfolio of patents. As the medical field continues to evolve, Finch's contributions will undoubtedly play a vital role in shaping the future of pharmaceutical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile